{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:16:45Z","timestamp":1782515805265,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["182356\u20132016"],"award-info":[{"award-number":["182356\u20132016"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["182356\u20132016"],"award-info":[{"award-number":["182356\u20132016"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2023,3,23]]},"DOI":"10.1038\/s41416-022-02097-7","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T20:05:28Z","timestamp":1671739528000},"page":"825-832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of ovarian cancer in women who give birth after assisted reproductive technology (ART)\u2014a registry-based Nordic cohort study with follow-up from first pregnancy"],"prefix":"10.1038","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8972-8254","authenticated-orcid":false,"given":"Marie S\u00f8fteland","family":"Sandvei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Pinborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv Bente","family":"Romundstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora E.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Spaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aila","family":"Tiitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla-Britt","family":"Wennerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Karina","family":"Henningsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Opdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"2097_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","volume":"41","author":"PM Webb","year":"2017","unstructured":"Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017;41:3\u201314.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2097_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/jnci\/djs197","volume":"104","author":"R Twombly","year":"2012","unstructured":"Twombly R. Too early to determine cancer risk from infertility treatments. J Natl Cancer Inst. 2012;104:501\u20132.","journal-title":"J Natl Cancer Inst"},{"key":"2097_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF. Incessant ovulation-a factor in ovarian neoplasia? Lancet. 1971;2:163.","journal-title":"Lancet"},{"key":"2097_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1056\/NEJM199409223311204","volume":"331","author":"MA Rossing","year":"1994","unstructured":"Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994;331:771\u20136.","journal-title":"N Engl J Med"},{"key":"2097_CR5","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992;136:1184\u2013203.","journal-title":"Am J Epidemiol"},{"key":"2097_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00432-015-2035-x","volume":"142","author":"R Kessous","year":"2016","unstructured":"Kessous R, Davidson E, Meirovitz M, Sergienko R, Sheiner E. The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up. J Cancer Res Clin Oncol. 2016;142:287\u201393.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2097_CR7","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1093\/humrep\/der322","volume":"26","author":"FE van Leeuwen","year":"2011","unstructured":"van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod. 2011;26:3456\u201365.","journal-title":"Hum Reprod"},{"key":"2097_CR8","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.fertnstert.2015.07.1135","volume":"104","author":"B Luke","year":"2015","unstructured":"Luke B, Brown MB, Spector LG, Missmer SA, Leach RE, Williams M, et al. Cancer in women after assisted reproductive technology. Fertil Steril. 2015;104:1218\u201326.","journal-title":"Fertil Steril"},{"key":"2097_CR9","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.fertnstert.2013.08.008","volume":"100","author":"B Trabert","year":"2013","unstructured":"Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, et al. Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort. Fertil Steril. 2013;100:1660\u20136.","journal-title":"Fertil Steril"},{"key":"2097_CR10","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.fertnstert.2012.12.029","volume":"99","author":"LA Brinton","year":"2013","unstructured":"Brinton LA, Trabert B, Shalev V, Lunenfeld E, Sella T, Chodick G. In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril. 2013;99:1189\u201396.","journal-title":"Fertil Steril"},{"key":"2097_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/humrep\/deq307","volume":"26","author":"B Kallen","year":"2011","unstructured":"Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod. 2011;26:253\u20138.","journal-title":"Hum Reprod"},{"key":"2097_CR12","doi-asserted-by":"publisher","first-page":"k2644","DOI":"10.1136\/bmj.k2644","volume":"362","author":"CL Williams","year":"2018","unstructured":"Williams CL, Jones ME, Swerdlow AJ, Botting BJ, Davies MC, Jacobs I, et al. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991\u20132010: data linkage study including 2.2 million person years of observation. BMJ. 2018;362:k2644.","journal-title":"BMJ"},{"key":"2097_CR13","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/humrep\/dev124","volume":"30","author":"MM Reigstad","year":"2015","unstructured":"Reigstad MM, Larsen IK, Myklebust TA, Robsahm TE, Oldereid NB, Omland AK, et al. Cancer risk among parous women following assisted reproductive technology. Hum Reprod. 2015;30:1952\u201363.","journal-title":"Hum Reprod"},{"key":"2097_CR14","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1158\/1055-9965.EPI-16-0809","volume":"26","author":"MM Reigstad","year":"2017","unstructured":"Reigstad MM, Storeng R, Myklebust TA, Oldereid NB, Omland AK, Robsahm TE, et al. Cancer risk in women treated with fertility drugs according to parity status\u2014a registry-based cohort study. Cancer Epidemiol Biomark Prev. 2017;26:953\u201362.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2097_CR15","first-page":"CD008215","volume":"6","author":"I Rizzuto","year":"2019","unstructured":"Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane database Syst Rev (Online). 2019;6:CD008215.","journal-title":"Cochrane database Syst Rev (Online)"},{"key":"2097_CR16","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/humrep\/deaa293","volume":"36","author":"JF Barcroft","year":"2021","unstructured":"Barcroft JF, Galazis N, Jones BP, Getreu N, Bracewell-Milnes T, Grewal KJ, et al. Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis. Hum Reprod. 2021;36:1093\u2013107.","journal-title":"Hum Reprod"},{"key":"2097_CR17","doi-asserted-by":"crossref","unstructured":"Lundberg FE, Iliadou AN, Rodriguez-Wallberg K, Gemzell-Danielsson K, Johansson ALV. The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study. Eur J Epidemiol. 2019;34:499\u2013507.","DOI":"10.1007\/s10654-018-0474-9"},{"key":"2097_CR18","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/aje\/kwm157","volume":"166","author":"SS Tworoger","year":"2007","unstructured":"Tworoger SS, Fairfield KM, Colditz GA, Rosner BA, Hankinson SE. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol. 2007;166:894\u2013901.","journal-title":"Am J Epidemiol"},{"key":"2097_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","volume":"14","author":"BM Reid","year":"2017","unstructured":"Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14:9\u201332.","journal-title":"Cancer Biol Med"},{"key":"2097_CR20","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/humrep\/dez165","volume":"34","author":"D Vassard","year":"2019","unstructured":"Vassard D, Schmidt L, Glazer CH, Lyng Forman J, Kamper-J\u00f8rgensen M, Pinborg A. Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study. Hum Reprod. 2019;34:2290\u20136.","journal-title":"Hum Reprod"},{"key":"2097_CR21","doi-asserted-by":"publisher","first-page":"hoac022","DOI":"10.1093\/hropen\/hoac022","volume":"2022","author":"C Wyns","year":"2022","unstructured":"European Ivf Monitoring Consortium f.t.E.S.o.H.R., Embryology, Wyns C, De Geyter C, Calhaz-Jorge C, Kupka MS, et al. ART in Europe, 2018: results generated from European registries by ESHRE. Hum Reprod Open. 2022;2022:hoac022.","journal-title":"Hum Reprod Open"},{"key":"2097_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1600-0412.2011.01145.x","volume":"90","author":"AK Henningsen","year":"2011","unstructured":"Henningsen AK, Romundstad LB, Gissler M, Nygren KG, Lidegaard O, Skjaerven R, et al. Infant and maternal health monitoring using a combined Nordic database on ART and safety. Acta Obstet Gynecol Scand. 2011;90:683\u201391.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2097_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/ije\/dyz228","volume":"49","author":"S Opdahl","year":"2020","unstructured":"Opdahl S, Henningsen AA, Bergh C, Gissler M, Romundstad LB, Petzold M, et al. Data Resource Profile: Committee of Nordic Assisted Reproductive Technology and Safety (CoNARTaS) cohort. Int J Epidemiol. 2020;49:365\u2013366f.","journal-title":"Int J Epidemiol"},{"key":"2097_CR24","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/humrep\/dey242","volume":"33","author":"C De Geyter","year":"2018","unstructured":"De Geyter C, Calhaz-Jorge C, Kupka MS, Wyns C, Mocanu E, Motrenko T, et al. ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod. 2018;33:1586\u2013601.","journal-title":"Hum Reprod"},{"key":"2097_CR25","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3109\/02841861003782017","volume":"49","author":"G Engholm","year":"2010","unstructured":"Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49:725\u201336.","journal-title":"Acta Oncol"},{"key":"2097_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1469-0705.1999.14010023.x","volume":"14","author":"TH Nguyen","year":"1999","unstructured":"Nguyen TH, Larsen T, Engholm G, M\u00f8ller H. Evaluation of ultrasound-estimated date of delivery in 17,450 spontaneous singleton births: do we need to modify Naegele\u2019s rule? Ultrasound Obstet Gynecol. 1999;14:23\u201328.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2097_CR27","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/ije\/dyab157","volume":"50","author":"MA Mansournia","year":"2021","unstructured":"Mansournia MA, Nazemipour M, Etminan M. Causal diagrams for immortal time bias. Int J Epidemiol. 2021;50:1405\u20139.","journal-title":"Int J Epidemiol"},{"key":"2097_CR28","doi-asserted-by":"crossref","unstructured":"Spaan M, van den Belt-Dusebout AW, Lambalk CB, van Boven HH, Schats R, Kortman M, et al. Long-term risk of ovarian cancer and borderline tumors after assisted reproductive technology. J Natl Cancer Inst. 2020;113:699\u2013709.","DOI":"10.1093\/jnci\/djaa163"},{"key":"2097_CR29","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/humrep\/dez018","volume":"34","author":"G Murugappan","year":"2019","unstructured":"Murugappan G, Li S, Lathi RB, Baker VL, Eisenberg ML. Risk of cancer in infertile women: analysis of US claims data. Hum Reprod. 2019;34:894\u2013902.","journal-title":"Hum Reprod"},{"key":"2097_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/humupd\/dms051","volume":"19","author":"C Siristatidis","year":"2013","unstructured":"Siristatidis C, Sergentanis TN, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I, et al. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer-a systematic review and meta-analysis. Hum Reprod Update. 2013;19:105\u201323.","journal-title":"Hum Reprod Update"},{"key":"2097_CR31","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ygyno.2012.10.023","volume":"128","author":"LM Stewart","year":"2013","unstructured":"Stewart LM, Holman CD, Aboagye-Sarfo P, Finn JC, Preen DB, Hart R. In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. Gynecol Oncol. 2013;128:260\u20134.","journal-title":"Gynecol Oncol"},{"key":"2097_CR32","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/0284186X.2017.1407039","volume":"57","author":"E Pukkala","year":"2018","unstructured":"Pukkala E, Engholm G, Hojsgaard Schmidt LK, Storm H, Khan S, Lambe M, et al. Nordic Cancer Registries\u2014an overview of their procedures and data comparability. Acta Oncol. 2018;57:440\u201355.","journal-title":"Acta Oncol"},{"key":"2097_CR33","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","volume":"354","author":"A Venn","year":"1999","unstructured":"Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet. 1999;354:1586\u201390.","journal-title":"Lancet"},{"key":"2097_CR34","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/humrep\/dex096","volume":"32","author":"SS Malchau","year":"2017","unstructured":"Malchau SS, Henningsen AA, Loft A, Rasmussen S, Forman J, Nyboe Andersen A, et al. The long-term prognosis for live birth in couples initiating fertility treatments. Hum Reprod. 2017;32:1439\u201349.","journal-title":"Hum Reprod"},{"key":"2097_CR35","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/aogs.12948","volume":"95","author":"M Gottschau","year":"2016","unstructured":"Gottschau M, Mellemkjaer L, Hannibal CG, Kjaer SK. Ovarian and tubal cancer in Denmark: an update on incidence and survival. Acta Obstet Gynecol Scand. 2016;95:1181\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2097_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","volume":"122","author":"LJ Havrilesky","year":"2013","unstructured":"Havrilesky LJ, Moorman PG, Lowery WJ, Gierisch JM, Coeytaux RR, Urrutia RP, et al. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013;122:139\u201347.","journal-title":"Obstet Gynecol"},{"key":"2097_CR37","doi-asserted-by":"publisher","first-page":"100542","DOI":"10.1016\/j.xcrm.2022.100542","volume":"3","author":"S Mortlock","year":"2022","unstructured":"Mortlock S, Corona RI, Kho PF, Pharoah P, Seo JH, Freedman ML, et al. A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes. Cell Rep Med. 2022;3:100542.","journal-title":"Cell Rep Med"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-02097-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-02097-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-02097-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:07:50Z","timestamp":1677715670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-02097-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,3,23]]}},"alternative-id":["2097"],"URL":"https:\/\/doi.org\/10.1038\/s41416-022-02097-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the registry-keeping authorities in each country. Permission was granted from the regional ethics committees in Norway (REC North 2010\/1909) and Sweden (Dnr 214-12, T422-12, T516-15, T233-16, T300-17, T1144-17, T121-18, T1071-18, T2019 02347). In Denmark and Finland, study-specific ethical approval is not required when using national registry data for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Non applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}